A controlled trial of combination chemotherapy with 5-FU and BCNU in pancreatic cancer

Research output: Contribution to journalJournal articleResearchpeer-review

Combined chemotherapy with 5-FU and BCNU was compared with placebo in a triple-blind, randomized study of 40 patients with pancreatic adenocarcinoma. There were no significant differences between the groups with regard to survival, tumor size, or quality of life.

Original languageEnglish
Book seriesScandinavian Journal of Gastroenterology
Volume16
Issue number8
Pages (from-to)973-975
Number of pages3
ISSN0036-5521
DOIs
Publication statusPublished - 1981
Externally publishedYes

    Research areas

  • Cancer chemotherapy, Pancreatic cancer, Survival

ID: 251993879